THE MINISTRY OF HEALTH
Circular No. 39/2017/TT-BYT dated October 18, 2017 of the Ministry of Health on basic package of health services applied to grassroots health facilities
Pursuant to the Law on Health Insurance No. 25/2008/QH12 dated November 14, 2008 amended by the Law No. 46/2014/QH13 dated June 13, 2014;
Pursuant to the Government’s Decree No. 75/2017/ND-CP dated June 20, 2017 defining Functions, Tasks, Powers and Organizational Structure of Ministry of Health;
Pursuant to the Resolution No. 68/2013/QH13 dated November 29, 2013 by the National Assembly on strict enforcement of regulations and policies on health insurance towards the universal health coverage;
At the request of the Director of the Department of Planning and Finance;
Minister of Health promulgates a Circular stipulating basic package of health services applied to grassroots health facilities.
Article 1. Scope of adjustment and subject of application
This Circular stipulates the basic package of health services, comprising medical procedures, drugs, chemicals and supplies used for providing initial health care, health improvement, preventive and curative services, applied to grassroots health facilities (i.e. commune-level and district-level health facilities) and all citizens of Vietnam.
Article 2. Basic package of health services
The basic package of health services comprises “basic package of health services covered by health insurance fund” and “basic package of health services for initial health care, preventive and health improvement purposes". To be specific:
1. “Basic package of health services covered by health insurance fund” comprises medical procedures specified in the Appendix I and the list of drugs used by commune-level health facilities mentioned in the Appendix II enclosed herewith and is applied to medical stations of communes, wards, towns and equivalents, private GP or family clinics, military-civilian medical stations and military – civilian clinics (hereinafter referred to as “commune-level health facilities).
2. “Basic package of health services for initial health care, preventive and health improvement purposes” comprises essential medical services prescribed in the Appendix III enclosed herewith and is applied to medical centers of urban/sub-urban districts, towns or provincial cities (hereinafter referred to as "district-level medical centers”) and medical stations of communes, wards or towns so as to provide healthcare services, preventive and health improvement services.
3. The basic package of health services shall be updated for every 1-2 years or at the request of a competent authority.
Article 3. Payment for health services in the “Basic package of health services covered by health insurance fund” (Appendix I and Appendix II)
1. When a holder of health insurance card uses health services in the basic package of health services, he/she may enjoy health insurance benefits according to the insurance coverage scope and levels prescribed by the Law on Health Insurance and the regulations herein.
2. A holder of health insurance card may receive payments for his/her use of any medical procedures, drugs and supplies or any other services, which are not included in the basic package of health services as prescribed herein at any health facilities nationwide, from the relevant social insurance agencies in accordance with regulations of the Law on Health Insurance.
3. Prices of medical procedures shall be set in accordance with regulations on prices of medical services and the Joint Circular No. 37/2015/TTLT-BYT-BTC dated October 29, 2015 by Ministry of Health and Ministry of Finance on prices of medical services covered by health insurance fund and consistently applied to hospitals of same levels nationwide.
4. Prices of drugs or medical supplies shall be set in accordance with regulations on bidding for purchase of medicines and medical supplies.
Article 4. Payment for health services in the “Basic package of health services for initial health care, preventive and health improvement purposes” (Appendix III)
1. Healthcare, preventive and health improvement services that are provided as duties of the Population & Health Target Program shall be covered by funding of the Population & Health Target Program as prescribed in the Decision No. 1125/QD-TTg dated July 31, 2017 by the Prime Minister giving approval for the Population & Health Target Program in the 2016 – 2020 period. Sources of funding, expenditure items and levels shall be governed by regulations of the Ministry of Finance.
2. Payment for healthcare, preventive and health improvement services provided for persons who are eligible to have medical expenses paid by the Government in accordance with applicable laws shall be paid in accordance with the regulations of Ministry of Finance.
3. Healthcare, preventive and health improvement services other than those prescribed in Clauses 1, 2 of this Article shall be covered by the funding for healthcare services allocated by local-government budgets in accordance with regulations in the Prime Minister’s Decision No. 46/2016/QD-TTg dated October 19, 2016 on provision of estimates of recurrent expenditures of the state budget in 2017.
4. Health services other than those prescribed in Clauses 1, 2, 3 of this Article shall be covered by users in accordance with applicable regulations, private contributions and other legal sources of funding.
Article 5. Implementationorganization
1. The Social Security Administration of Vietnam shall instruct social insurance agencies at all levels to make full payments for health services in the “basic package of health services covered by health insurance fund” actually provided for patients who holding health insurance cards by health facilities in accordance with guidelines herein and relevant laws.
2. People’s Committees of provinces or central-affiliated cities shall instruct People’s Committees at lower levels, Provincial Departments of Health and related departments to:
a) allocate funding from local-government budget, funding of the National target program for development of advanced rural areas and other legal sources of funding (if any) to invest in material facilities and equipment of medical stations of communes, wards or towns in an effective manner. To be specific:
- give priority to medical stations capable of providing health services in both basic packages of health services, especially medical stations in remote regions or disadvantaged regions; limit investments in medical stations of communes, wards or towns near to two-functions medical centers of districts or near to hospitals;
- conform to local existing conditions and regulations in the Decision No. 4667/QD-BYT dated November 07, 2014 by Ministry of Health on promulgation of national criteria for health facilities of communes by 2020 (hereinafter referred to as the Decision No. 4667/QD-BYT).
b) arrange human resources for health facilities to provide health services in the basic package of health services. Instruct the application of two-ways rotation of medical staff in conformity with local conditions to improve knowledge and professional skills of medical staff of health facilities. Establish principles for arrangement of working schedule for medical staff that medical staff of medical centers of urban/sub-urban districts, towns or provincial cities must work at medical stations of communes or wards in certain days of the week and medical staff of medical stations of communes, wards or towns must work on rotation at medical centers of districts according to the plan and ensure financial resources to implement duties of the Decision No. 14/2013/QD-TTg dated February 20, 2013 by the Prime Minister on application of mechanism for fixed-term rotation of medical staff of health facilities;
c) With regard to the basic package of health services covered by health insurance fund, People’s Committees of provinces or central-affiliated cities shall:
- Instruct health facilities to provide the basic package of health services for holders of health insurance cards under the scope of its management;
- Instruct Provincial Departments of Health and Provincial Social Insurance Agencies to make payments for health services in the basic package of health services provided by health facilities in accordance with regulations herein and relevant laws;
d) With regard to the basic package of health services for initial health care, preventive and health improvement purposes, People’s Committees of provinces or central-affiliated cities shall:
- Ensure funding and instruct local health facilities to provide health services for initial health care, preventive and health improvement purposes for people as well as healthcare services for persons given priority as regulated by laws;
- Request the Provincial-level People’s Councils to make decision within their competence on use of funding from state budget and other legal sources of funding to provide health services in the basic package of health services prescribed in the Appendix III enclosed herewith.
- Mobilize contributions from private sectors to provide healthcare, preventive and health improvement services.
3. Provincial Departments of Health shall:
a) With regard to the basic package of health services covered by health insurance fund:
- Instruct health facilities of communes to provide services in the basic package of health services in compliance with regulations herein;
- Ensure that health facilities shall have enough drugs, medical supplies and chemicals to provide health services in the basic package of health services;
- Cooperate with provincial departments, competent authorities and social insurance agencies at all levels to make payments for health services in the basic package of health services provided by health facilities in accordance with regulations herein and relevant laws;
b) With regard to basic package of health services covered by state budget and other legal sources of funding:
- Instruct the provision of basic package of health services at grassroots health facilities;
- Cooperate with provincial departments and competent authorities at all levels to ensure funding to make payments for health services in the basic package of health services provided by health facilities in accordance with relevant laws;
c) Give advice to Provincial People s Committees about setting up the route for investment in material facilities and equipment of health facilities in conformity with current status of each health facility as well as regulations in the Decision No. 4667/QD-BYT;
d) Instruct and inspect health facilities so as to ensure that health services in the basic package of health services shall be provided in conformity with their professional and technical conditions and relevant laws;
dd) Cooperate with health facilities that are licensed and granted training codes to organize training or drilling courses so as to improve professional knowledge and skills of medical staff of health facilities providing basic package of health services.
4. Medical centers and health facilities of districts shall:
a) Provide health services in the basic package of health services in accordance with regulations herein;
b) Instruct medical stations of communes under the scope of their management to provide enough drugs, medical supplies and services in the basic package of health services;
c) Manage and inspect medical stations in providing health services in the basic package of health services to people, managing and using drugs and medical supplies, and make payment for medical stations in accordance with relevant laws.
5. Health facilities prescribed herein shall provide health services in the basic package of health services in accordance with the law.
Article 6.Effect
This Circular takes effect on December 01, 2017.
Article 7. Referenceprovisions
If legislative documents referred to herein are superseded or amended, the new ones shall prevail.
Any difficulties arising in the course of implementation of this Circular shall promptly reported to the Ministry of Health (via Department of Planning & Finance) for consideration./.
The Minister
Nguyen Thi Kim Tien
APPENDIX I
LIST OF MEDICAL PROCEDURES IN THE BASIC PACKAGE OF HEALTH SERVICES
(Attached with the Circular No. 39/2017/TT-BYT dated October 18, 2017 by Minister of Health)
No. | Codes prescribed in the Circular No. 43/2013/TT-BYT, the Circular No. 21/2017/TT-BYT | Codes prescribed in the Joint Circular No. 37/2015/TTLT-BYT-BTC | Medical procedures |
(1) | (2) | (3) | (4) |
1. | - | | Medical examination |
2. | 3.2387 | 37.8B00.0212 | Intradermal injection |
3. | 3.2388 | 37.8B00.0212 | Subcutaneous injection |
4. | 3.2389 | 37.8B00.0212 | Intramuscular injection |
5. | 3.2390 | 37.8B00.0212 | Intravenous injection |
6. | 3.2391 | 37.8B00.0215 | Intravenous infusion |
7. | 1.6 | | Peripheral intravenous catheter insertion |
8. | 1.51 | | Critical care and shock treatment up to 8 hours |
9. | 1.218 | 37.8B00.0159 | Gastric lavage in emergency cases |
10. | 1.160 | 37.8B00.0210 | Urinary bladder catheterization |
11. | 1.64 | | Heimlich maneuver (abdominal thrusts) for adults and children |
12. | 1.275 | | Wound dressings |
13. | 1.65 | 37.8B00.0071 | Ambu bag-mask ventilation |
14. | 1.158 | 37.8B00.0074 | Basic emergency skills to treat respiratory – circulation failure |
15. | 1.74 | 37.8B00.0120 | Single-dilator percutaneous tracheostomy for emergency treatment of choking |
16. | - | | Breathing support |
17. | - | | Oxygen breathing technique |
18. | 1.215 | | Forced emesis for gastrointestinal decontamination of poisoned patient |
19. | 1.157 | 37.8D05.0508 | Fixation of rib fractures |
20. | 1.269 | | Pressure bandaging in snakebite first aid |
21. | 1.270 | | Tourniquets or haemostatic dressings |
22. | 1.0276 | | Provisional fixation of bone fractures |
23. | 1.0277 | | Cervical spine stabilization by splints |
24. | 1.5 | | Capillary refill tests |
25. | - | | Emergency cricothyrotomy |
26. | 1.281 | 37.1E03.1510 | Capillary blood glucose tests |
27. | 23.201 | | Urinary protein quantification |
28. | 22.279, 22.280, 22.283 | | ABO blood group determination |
29. | - | | Sample collection and shipment |
30. | 2.314 | 37.2A01.0001 | Abdominal ultrasound |
31. | 21.14 | 37.3F00.1778 | Conventional ECG |
32. | 2.10 | | Thoracentesis for removing fluid from the pleural space |
33. | 2.11 | | Thorcentesis for removing air from the pleural space |
34. | 2.243 | | Therapeutic abdominal paracentesis |
35. | 2.14 | | Measuring asthma severity using peak flow meter |
36. | 21.13 | | Tourniquet test |
37. | 2.244 | 37.8B00.0103 | Stomach tube placement |
38. | 2.247 | 37.8B00.0211 | Rectal tube placement |
39. | 2.339 | 37.8B00.0211 | Enema administration technique |
40. | 2.243 | 37.8B00.0078 | Diagnostic abdominal paracentesis |
41. | 3.1706 | 37.8D07.0782 | Conjunctival foreign body removal |
42. | 3.3827 | 37.8B00.0216 | Suturing of flesh wounds |
43. | 3.3909 | 37.8D05.0505 | Small abscess incision and drainage |
44. | 3.3826 | 37.8B00.0075 | Wound dressing, suture removal |
45. | 3.4246 | 37.8B00.0198 | Removal of plaster casts of various types |
46. | 3.2119 | 37.8D05.0505 | Incision and drainage of furuncle in external auditory canal |
47. | 3.2120 | 37.8D08.0899 | Administration of ear medications |
48. | 3.1955 | 37.8D09.1029 | Milk teeth removal |
49. | 3.2245 | 37.8B00.0216 | Simple suturing of wounds around head, face or neck |
50. | 3.3909 | 37.8D05.0505 | Incision and drainage of small abscesses on head or neck |
51. | 3.3821 | 37.8B00.0216 | Cutting necrotic tissues or wound debridement |
52. | 14.206 | 37.8D07.0730 | Lacrimal dilation and syringing |
53. | 14.207 | 37.8D07.0738 | Incision and drainage of an external stye, hordeolum and chalazion; conjunctival or eyelid abscess incision |
54. | 14.211 | 37.8D07.0842 | Eye orbital syringing |
55. | 14.260 | | Optometry |
56. | 15.222 | 37.8D08.0898 | Nasal and oral inhalation |
57. | 15.56 | 37.8D08.0882 | Removing fluid from the pinna |
58. | 15.42 | | Periodontal abscess incision and drainage for children |
59. | 13.33 | 37.8D06.0614 | Normal labour (vertex delivery) |
60. | 13.34 | | Perineum cutting and suturing |
61. | 13.166 | 37.8D06.0715 | Pap test |
62. | 13.167 | | Intravaginal administration |
63. | 13.40 | 37.8D06.0629 | Treatment of infected perineal stitches |
64. | 13.37 | | Uterine massage |
65. | 13.38 | | Manual placenta removal |
66. | 8.26 | 37.8C00.0222 | Herbal dressing |
67. | 8.27 | 37.8C00.0228 | Mugwort compress |
68. | 3.289 | 37.8C00.0224 | Dry needling |
69. | 3.291 | 37.8C00.0224 | Fire needle acupuncture |
70. | 8.10 | 37.8C00.0224 | Hemo-acupuncture |
71. | 8.5 | 37.8C00.0230 | Electro-acupuncture |
72. | 3.4183 | 37.8C00.0271 | Aqua-acupuncture |
73. | 8.9 | 37.8C00.0228 | Moxibustion (using moxa) |
74. | 8.483 | 37.8C00.0280 | Massage and acupressure therapy |
75. | 17.11 | 37.8C00.0237 | Infrared light therapy |
76. | 17.53 | 37.8C00.0267 | Active-assisted range of motion (ROM) exercises |
APPENDIX II
LIST OF DRUGS IN THE BASIC PACKAGE OF HEALTH SERVICES
(Attached with the Circular No. 39/2017/TT-BYT dated October 18, 2017 by Minister of Health)
I. LIST OF DRUGS IN THE BASIC PACKAGE OF HEALTH SERVICES
No. | NAME OF DRUG | ROUTE OF ADMINISTRATION | NOTE |
(1) | (2) | (3) | (4) |
1. ANAESTHETICS AND MEDICAL OXYGEN | |
1 | Atropin sulfate | Injection | |
2 | Diazepam | Injection | Drugs used in emergencies shall be covered by the health insurance fund |
3 | Lidocaine (hydride) | Injection | |
4 | Lidocaine + epinephrine (adrenaline) | Injection | |
5 | Medical oxygen | Respiratory tract | |
6 | Procaine hydrocloride | Injection | |
2. ANALGESICS, PALLIATIVE CARE MEDICINES; MEDICINES USED FOR GOUT | |
2.1. Analgesics | |
7 | Diclofenac | Oral administration | |
8 | Ibuprofen | Oral administration | |
9 | Meloxicam | Oral administration | |
10 | Morphine (hydride, sulfate) | Injection | Drugs used in emergencies shall be covered by the health insurance fund |
11 | Paracetamol | Oral, rectal administration | |
12 | Piroxicam | Oral administration | |
2.2. Palliative care medicines | |
13 | Amitriptyline | Oral administration | |
14 | Dexamethasone | Oral administration | |
15 | Diazepam | Injection, oral administration | Drugs taken by injection shall be covered by the health insurance fund. |
16 | Docusate sodium | Oral administration | |
17 | Lactulose | Oral administration | |
2.3. Medicines used for Gout | |
18 | Allopurinol | Oral administration | |
19 | Colchicine | Oral administration | |
3. ANTIALLERGICS AND MEDICINES FOR TREATMENT OF ANAPHYLACTIC REACTIONS | |
20 | Epinephrine (adrenalin) | Injection | |
21 | Alimemazine | Oral administration | |
22 | Chlorpheniramine (hydride maleate) | Oral administration | |
23 | Dexamethasone | Oral administration | |
24 | Loratadine | Oral administration | |
25 | Methylprednisolone | Injection | |
26 | Prednisolone | Oral administration | |
27 | Promethazine (hydride) | Oral administration | |
4. ANTIDOTES AND MEDICINES FOR POISONING CASES | |
28 | Acetylcystein | Injection, oral administration | |
29 | Atropine (sulfate) | Injection | |
30 | Vitamin B12 (Cyanocobalamin, Hydride) | Injection | |
31 | DL-Methionine | Oral administration | |
32 | Sodium thiosulfate | Injection | |
33 | Activated charcoal | Oral administration | |
34 | Methylene blue | Injection | |
5. ANTISEIZURE DRUGS, ANTIEPILEPTICS | |
35 | Sodium valproate | Oral administration | |
36 | Diazepam | Oral, injection | Drugs taken by injection shall be covered by the health insurance fund. |
37 | Phenobarbital | Oral, injection | |
38 | Phenytoin | Oral administration | |
6. ANTI-PARASITIC AND ANTIBACTERIAL DRUGS | |
6.1. Anthelminthics | |
39 | Albendazole | Oral administration | |
40 | Mebendazole | Oral administration | |
41 | Niclosamid | Oral administration | |
42 | Praziquantel | Oral administration | |
43 | Pyrantel | Oral administration | |
44 | Praziquantel | Oral administration | |
45 | Triclabendazole | Oral administration | |
6.2. Antibacterials | |
6.2.1. Beta-lactam medicines | |
46 | Amoxicilin | Oral administration | |
47 | Amoxicilinand clavulanic acid | Oral administration | |
48 | Ampicillin (sodium) | Injection | |
49 | Benzathine benzylpenicillin | Injection | |
50 | Benzylpenicilin | Injection | |
51 | Procaine benzylpenicilin | Injection | |
52 | Cefalexin | Oral administration | |
53 | Cefixime | Oral administration | |
54 | Cefuroxime | Oral administration | |
55 | Cloxacillin | Oral, injection | |
56 | Phenoxymethyl penicillin | Oral administration | |
6.2.2. Aminoglycoside medicines | |
57 | Gentamicin | Injection | |
6.2.3. Chloramphenicol medicine | |
58 | Cloramphenicol | Oral administration | |
6.2.4. Nitroimidazole medicine | |
59 | Metronidazole | Oral, rectal administration | |
6.2.5. Lincosamide medicine | |
60 | Clindamycin | Oral administration | |
6.2.6. Macrolide medicine | |
61 | Erythromycin | Oral administration | |
6.2.7. Quinolone medicine | |
62 | Ciprofloxacin | Oral administration | |
6.2.8. Sulfamide medicine | |
63 | Sulfamethoxazole and trimethoprim | Oral administration | |
6.2.9. Nitrofuran medicine | |
64 | Nitrofurantoin | Oral administration | |
6.2.10. Tetracycline medicine | |
65 | Doxycycline | Oral administration | |
6.3. Tuberculosis drugs | |
66 | Ethambutol | Oral administration | |
67 | Isoniazid | Oral administration | |
68 | Pyrazinamide | Oral administration | |
69 | Rifampicin | Oral administration | |
70 | Rifampicin and isoniazid | Oral administration | |
71 | Streptomycin | Injection | |
72 | Ethambutol and isoniazid | Oral administration | |
73 | Ethambutol + isoniazid + pyrazinamide + rifampicin | Oral administration | |
74 | Ethambutol + isoniazid + rifampicin | Oral administration | |
75 | Isoniazid + pyrazinamide + rifampicin | Oral administration | |
6.4. Antifungal medicines | |
76 | Clotrimazole | Intravaginal, topical administration | |
77 | Fluconazole | Oral administration | |
78 | Griseofulvin | Oral administration | |
79 | Nystatin | Oral, intravaginal administration | |
6.5. Antiamoebic drugs | |
80 | Diloxanide (furoate) | Oral administration | |
81 | Metronidazole | Oral administration | |
6.6. Antimalarial medicines | |
82 | Amodiaquine | Oral administration | |
83 | Cloroquine | Oral administration | |
84 | Doxycycline | Oral administration | |
85 | Primaquine | Oral administration | |
86 | Quinine | Oral administration | |
6.7. Antiviral drugs | |
87 | Acyclovir | Oral, topical administration | |
88 | Abacavir (ABC) | Oral administration | Comply with the Ministry of Health’s Guidance on HIV/AIDS management, treatment and care. |
89 | Efavirenz | Oral administration |
90 | Lamivudine | Oral administration |
91 | Nevirapine | Oral administration |
92 | Tenofovir (TDF) | Oral administration |
93 | Ritonavir | Oral administration |
94 | Zidovudine | Oral administration |
95 | Lopinavir and ritonavir | Oral administration |
96 | Lamivudine + tenofovir | Oral administration |
97 | Lamivudine + tenofovir + efavirenz | Oral administration |
98 | Lamivudine + zidovudine + nevirapine | Oral administration |
99 | Lamivudine + zidovudine | Oral administration |
7. ANTIMIGRAINE MEDICINES | |
100 | Ibuprofen | Oral administration | |
101 | Paracetamol | Oral administration | |
102 | Propranolol hydrdocloride | Oral administration | |
8. ANTIPARKINSONISM MEDICINES | |
103 | Biperideu | Oral administration | |
104 | Levodopa + carbidopa | Oral administration | |
9. MEDICINES AFFECTING THE BLOOD | |
9.1. Antianaemia medicines | |
105 | Folic acid (vitamin B9) | Oral administration | |
106 | Ferrous sulfate (or oxalate) | Oral administration | |
107 | Ferrous sulfate + folic acid | Oral administration | |
108 | Vitamin B12 (Cyanocobalamin, Hydride) | Injection | |
9.2. Medicines affecting coagulation | |
109 | Tranexamic acid | Oral administration | |
110 | Phytomenadion (vitamin K1) | Oral, injection | |
9.3. Macromolecular solution | |
111 | Dextran 40 | Infusion | |
10. CADIOVASCULAR MEDICINES | |
10.1. Antianginal medicines | |
112 | Atenolol | | |
113 | Glyceryl trinitrat (Nitroglycerin) | Oral, sublingual administration | |
114 | Isosorbid (dinitrat or mononitrat) | Oral, sublingual administration | |
10.2. Antiarrhythmic medicines | |
115 | Amiodaron (hydroclorid) | Oral administration | |
116 | Atenolol | Oral administration | |
117 | Lidocain (hydroclorid) | Injection | |
118 | Propranolol (hydroclorid) | Oral administration | |
119 | Verapamil (hydroclorid) | Oral administration | |
120 | Digoxin | Injection | Drugs used in emergencies shall be covered by the health insurance fund |
121 | Epinephrin (adrenalin) | Injection | |
10.3. Antihypertensive medicines | |
122 | Amlodipin | Oral administration | |
123 | Atenolol | Oral administration | |
124 | Captopril | Oral administration | |
125 | Enalapril | Oral administration | |
126 | Furosemid | Oral administration | |
127 | Hydroclorothiazid | Oral administration | |
128 | Methyldopa | Oral administration | |
129 | Nifedipin | Oral administration | |
130 | Propranolol hydroclorid | Oral administration | |
10.4. Hypotension medicines | |
131 | Heptaminol (hydroclorid) | Oral administration | |
10.5. Medicines used for heart failure | |
132 | Digoxin | Injection | Drugs used in emergencies shall be covered by the health insurance fund |
133 | Epinephrin (adrenalin) | Injection | |
134 | Enalapril | | |
135 | Furosemid | Oral, injection | Drugs taken by injection shall be covered by the health insurance fund. |
136 | Hydroclorothiazid | Oral administration | |
137 | Spironolacton | Oral administration | |
10.6. Antithrombotic medicines | |
138 | Acetylsalicylic acid | Oral administration | |
10.7. Hypolipidemic Medicines | |
139 | Atorvastatin | Oral administration | |
140 | Fenofibrat | Oral administration | |
141 | Simvastatin | Oral administration | |
11. DERMATOLOGICAL MEDICINES | |
11.1. Antifungal medicines | |
142 | Benzoic acid + Salicylic acid | Topical administration | |
143 | A.S.A alcohol | Topical administration | |
144 | BSI alcohol | Topical administration | |
145 | Clotrimazol | Topical administration | |
146 | Ketoconazol | Topical administration | |
147 | Miconazol | Topical administration | |
11.2. Antibacterials | |
148 | Povidon iod | Topical administration | |
149 | Silver Sulfadiazin | Topical administration | |
11.3. Anti-inflammatory and antipruritic medicines | |
150 | Betamethason | Topical administration | |
151 | Fluocinolon acetonid | Topical administration | |
152 | Hydrocortison | Topical administration | |
11.4. Medicines affecting skin differentiation and proliferation | |
153 | Salicylic acid | Topical administration | |
11.5. Scabicides | |
154 | Diethylphtalat | Topical administration | |
12. DIAGNOSTIC AGENTS | |
155 | Bari sulfat | Oral administration | |
13. DISINFECTANTS AND ANTISEPTICS | |
156 | 70-degree Alcohol | Topical administration | |
157 | Alcohol iod | Topical administration | |
158 | Povidon iod | Topical administration | |
14. DIURETICS | |
159 | Furosemid | Oral, injection | Drugs taken by injection shall be covered by the health insurance fund. |
160 | Hydroclorothiazid | Oral administration | |
161 | Spironolacton | Oral administration | |
15. GASTROINTESTINAL MEDICINES | |
15.1. Stomach acid neutralizers and inhibitors | |
162 | Bismuth | Oral administration | |
163 | Cimetidin | Oral administration | |
164 | Famotidin | Oral, injection | |
165 | Magnesi hydroxyd + nhôm hydroxyd | Oral administration | |
166 | Omeprazol | Oral administration | |
167 | Ranitidin | Oral administration | |
15.2. Antiemetics | |
168 | Dexamethason | Oral administration | |
169 | Metoclopramid | Oral administration | |
170 | Promethazin (hydroclorid) | Oral administration | |
15.3. Antispasmodic medicines | |
171 | Alverin (citrat) | Oral, injection | |
172 | Atropin (sulfat) | Oral, injection | |
173 | Hyoscin butylbromid | Oral administration | |
174 | Papaverin hydroclorid | Oral, injection | |
15.4. Laxatives | |
175 | Bisacodyl | Oral administration | |
176 | Magnesi sulfat | Oral administration | |
15.5. Anti-diarrhoea medicines | |
a. Rehydration | |
177 | Natri clorid + natri citrat + kali clorid + dehydrated glucose | Oral administration | |
b. Anti-diarrheal | |
178 | Activated mormoiron attapulgite | Oral administration | |
179 | Berberin (hydroclorid) | Oral administration | |
180 | Loperamid | Oral administration | |
181 | Zinc sulfate | Oral administration | |
15.6. Other medicines | |
182 | Amylase + lipase + protease | Oral administration | |
16. HORMONES AND ENDOCRINE MEDICINES | |
16.1. Adrenal hormones and synthetic substitutes | |
183 | Dexamethason | Oral administration | |
184 | Hydrocortison | Oral administration | |
185 | Prednisolon acetat | Oral administration | |
16.2. Antidiabetic medicines | |
186 | Gliclazid | Oral administration | |
187 | Metformin | Oral administration | |
188 | Insulin (Medium-acting, Intermediate-acting) | Injection | Comply with the Ministry of Health’s Guidance on diagnosis, treatment and management of diabetes mellitus. |
189 | Insulin (Fast-acting, Short-acting) | Injection |
190 | Insulin (Mixtard-acting, Dual-acting) | Injection |
191 | Insulin (Slow-acting, Long-acting) | Injection |
17. SERA | |
192 | Antitetanus sera | Injection | |
193 | Antivenom sera | Injection | |
18. MEDICINES FOR EYES, EARS, NOSE AND THROAT | |
18.1. Antibacterials, antivirals | |
194 | Aciclovir | Eye ointment | |
195 | Argyrol | Eye drops | |
196 | Cloramphenicol | Eye drops | |
197 | Gentamicin (sulfat) | Eye drops | |
198 | Neomycin (sulfat) | Eye drops, ear drops | |
199 | Ofloxacin | Eye drops, ear drops | |
200 | Tetracyclin (hydroclorid) | Eye ointment | |
201 | Ciprofloxacin | Eye drops | |
18.2. Miosis medicines | |
202 | Atropin (sulfat) | Eye drops | |
18.3. Medicines for ears, nose and throat | |
203 | Hydrogen peroxide | Topical administration | |
204 | Naphazolin | Nasal drops | |
205 | Xylometazolin | Nasal drops | |
19. OXYTOCICS, HAEMOSTASTICS AND ANTIOXYTOCICS | |
19.1. Oxytocics, haemostastics | |
19.1.1. Oxytocics | |
206 | Oxytocin | Injection | |
19.1.2. Haemostastics | |
207 | Ergometrin (hydrogen maleat) | Injection | |
208 | Oxytocin | Injection | |
209 | Misoprostol | Oral administration | |
19.2. Antioxytocics | |
210 | Papaverin | Oral administration | |
211 | Salbutamol (sulfat) | Oral administration | |
212 | Nifedipin | Oral administration | |
20. MEDICINES FOR MENTAL DISORDERS | |
20.1. Medicines used in psychotic disorders | |
213 | Clorpromazin (hydroclorid) | Oral administration | |
214 | Diazepam | Oral, injection | Drugs taken by injection in emergencies shall be covered by the health insurance fund. |
215 | Haloperidol | Oral administration | |
216 | Levomepromazin | Oral administration | |
20.2. Antidepressant | |
217 | Amitriptylin (hydroclorid) | Oral administration | |
21. MEDICINES ACTING ON THE RESPIRATORY TRACT | |
21.1. Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease | |
218 | Epinephrin (adrenalin) | Injection | |
219 | Budesonid | Respiratory tract | |
220 | Salbutamol (sulfat) | Oral, respiratory tract | |
221 | Terbutalin | Oral, respiratory tract | |
21.2. Medicines to treat paracrisis | |
222 | Acetylcystcin | Oral, injection | |
223 | Alimemazin | Oral administration | |
224 | Bromhexin (hydroclorid) | Oral administration | |
21.3. Other medicines | |
225 | Dextromethorphan | Oral administration | |
22. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE | |
22.1. Oral medications | | |
226 | Natri clorid + natri citrat + kali clorid + dehydrated glucose | Oral administration | |
227 | Kali clorid | Oral administration | |
22.2. Infusion medicines | |
228 | Glucose | Injection | |
229 | Ringer lactat | Infusion | |
230 | Calci clorid | Injection | |
231 | Natri clorid | Injection | |
232 | Natri hydrocarbonat (natri bicarbonat) | Injection | |
22.3. Other medicines | |
233 | Water miscible injection | Injection | |
23. VITAMIN AND INORGANICS | |
234 | Calci gluconat | Oral administration | |
235 | Vitamin A | Oral administration | |
236 | Vitamin A + D | Oral administration | |
237 | Vitamin B1 | Oral, injection | |
238 | Vitamin B2 | Oral administration | |
239 | Vitamin B6 | Oral administration | |
240 | Vitamin C | Oral administration | |
241 | Vitamin PP | Oral administration | |
II. GUIDANCE ON USE OF DRUGS IN THE BASIC PACKAGE OF HEALTH SERVICES
1. List of drugs in the basic package of health services comprises:
a) 241 drugs stated in Section I Appendix II.
b) Drugs that contain active ingredients as isomers or other salts and have same effects with the active ingredients stated in Section I Appendix II.
2. Administration routes specified in the list are stipulated as follows:
a) Orally administered medicines include: tablets to swallow, chew, lozenges, sublingual tablets;
b) Injection includes intramuscular injection, subcutaneous injection, intradermal injection, intravenous injection, intravenous infusion, intra-articular injection, intravitreal injection, intraperitoneal injection;
c) Rectal suppositories include vaginal suppositories, rectal suppositories, and enema;
d) Topically administered medicines include topical cream, transdermal patches, transdermal spray;
dd) Medicines administered through the respiratory tract include nebulizers, vaporizers, dry power inhalers, and aerosol;
e) Ocular medications include eye drops and eye ointment.
g) Nasal medications include nasal drops and nasal sprays.
3. Medicines in one group may be used for treatment of diseases in another group if having appropriate indications./.
APPENDIX III
LIST OF ESSENTIAL HEALTH SERVICES IN THE BASIC PACKAGE OF HEALTH SERVICES FOR INITIAL HEALTH CARE, PREVENTIVE AND HEALTH IMPROVEMENT PURPOSES
(Attached with the Circular No. 39/2017/TT-BYT dated October 18, 2017 by Minister of Health)
1. Services of health improvement, education, communication and consultancy, including foods and drinks, physical training, healthy living, stress control and prevention, etc.;
2. Vaccination services;
3. Personal healthcare services;
4. Infectious disease prevention and control services;
5. Mother and child care, and family planning services;
6. Nutrition and foods safety consulting and communication services;
7. Services of educating, disseminating and encouraging people to use clean water, protect environment, using toilets, etc.;
8. Non-communicable disease prevention and control services;
9. Health risk control services, including tobacco hazards prevention or alcohol abuse, etc.;
10. Community mental health services;
11. School health services;
12. Safe blood and blood-related disease prevention services;
13. Healthcare services for priority persons, including healthcare services for the elderly, people with disabilities, children and pregnant women, etc.;
14. Rehabilitation services for people with disabilities in community;
15. Healthcare services at home, including rehabilitation, physiotherapy, cancer prevention services;
16. Screening services to detect diseases for high-risk groups in community;
17. Services of providing essential medicines, including medicine cabinets.
Vietnamese
Circular 39/2017/TT-BYT DOC (Word)
Circular 39/2017/TT-BYT PDF (Original)
Circular 39/2017/TT-BYT ZIP (Word)
